346691-69-8

Basic information

• Product Name: tetraethyl (2-bromo-1,4-phenylene)bis(methylene)diphosphonate
• Synonyms: tetraethyl (2-bromo-1,4-phenylene)bis(methylene)diphosphonate
• CAS NO: 346691-69-8
• Molecular Weight: 457.238
• Mol File: 346691-69-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: tetraethyl (2-bromo-1,4-phenylene)bis(methylene)diphosphonate(CAS DataBase Reference)
• NIST Chemistry Reference: tetraethyl (2-bromo-1,4-phenylene)bis(methylene)diphosphonate(346691-69-8)
• EPA Substance Registry System: tetraethyl (2-bromo-1,4-phenylene)bis(methylene)diphosphonate(346691-69-8)

Safety Data

• Hazardous Substances Data: 346691-69-8(Hazardous Substances Data)

Upstream product

• 553-94-6 4-bromo-m-xylene 
• 19900-52-8 1,4-bisbromomethyl-2-bromobenzene 
• 122-52-1 triethyl phosphite 

Downstream Products

• 346691-71-2 (E,E)-1-bromo-2,5-bis-(3-methoxycarbonyl-4-hydroxy)styrylbenzene 
• 346691-75-6 (E,E)-2,5-bis(4’-methoxy-3’-carbomethoxystyryl)-1-iodobenzene 
• 346691-76-7 (E,E)-2,5-bis(4’-hydroxy-3’-carbomethoxystyryl)-1-iodobenzene 
• 291766-06-8 (E,E)-2,5-bis(4’-hydroxy-3’-carboxystyryl)-1-bromobenzene 
• 346691-70-1 (E,E)-1-bromo-2,5-bis-(3-methoxycarbonyl-4-methoxy)styrylbenzene 

Relevant articles and documents

Tritium-labeled (E,E)-2,5-bis(4′-hydroxy-3′-carboxystyryl)benzene as a probe for β-amyloid fibrils

Accumulation of Aβ in the brains of Alzheimer disease (AD) patients reflects an imbalance between Aβ production and clearance from their brains. Alternative cleavage of amyloid precursor protein (APP) by processing proteases generates soluble APP fragments including the neurotoxic amyloid Aβ40 and Aβ42 peptides that assemble into fibrils and form plaques. Plaque-buildup occurs over an extended time-frame, and the early detection and modulation of plaque formation are areas of active research. Radiolabeled probes for the detection of amyloid plaques and fibrils in living subjects are important for noninvasive evaluation of AD diagnosis, progression, and differentiation of AD from other neurodegenerative diseases and age-related cognitive decline. Tritium-labeled (E,E)-1-[3H]-2,5-bis(4′-hydroxy-3′-carbomethoxystyryl)benzene possesses an improved level of chemical stability relative to a previously reported radioiodinated analog for radiometric quantification of Aβ plaque and tau pathology in brain tissue and in vitro studies with synthetic Aβ and tau fibrils.